Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B (LB80380)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by LG Life Sciences.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
LG Life Sciences Identifier:
First received: November 12, 2010
Last updated: April 13, 2012
Last verified: April 2012